Literature DB >> 26870925

Intraperitoneal bupivacaine with or without incisional bupivacaine for postoperative analgesia in dogs undergoing ovariohysterectomy.

Karin S Kalchofner Guerrero1, Ivo Campagna2, Rodolfo Bruhl-Day1, Cecilia Hegamin-Younger3, Tomas G Guerrero1.   

Abstract

OBJECTIVE: Intraperitoneal (IP) bupivacaine provides postoperative analgesia in dogs undergoing ovariohysterectomy (OHE) alone or in combination with incisional (INC) bupivacaine. This study investigated whether the combination of INC and IP bupivacaine is superior to IP bupivacaine alone. STUDY
DESIGN: Prospective, randomized, blinded clinical study. ANIMALS: Thirty-nine privately owned dogs undergoing OHE, aged 25 ± 23 months and weighing 11.8 ± 5.7 kg.
METHODS: Dogs were premedicated with acepromazine (0.05 mg kg(-1) ) and morphine (0.5 mg kg(-1) ) intramuscularly (IM); anaesthesia was induced with propofol and maintained with isoflurane in oxygen. Carprofen (4 mg kg(-1) ) was administered subcutaneously (SC) after intubation. Bupivacaine (3 mg kg(-1) ) IP was administered before complete closure of the linea alba to all dogs. Dogs were randomly assigned into two groups: group B received bupivacaine (n = 20; 1 mg kg(-1) ) and group S received saline (n = 19; 0.2 mL kg(-1) ) INC as a subcutaneous 'splash' before skin closure. Postoperative analgesia was assessed with a dynamic interactive visual analogue scale, the short form of the Glasgow Composite Pain Scale, and mechanical nociceptive threshold (MNT) measurement at 0.5, 1, 2, 4, 6, 8, 12 and 20 hours after surgery by one blinded observer. Parametric data were tested using t-test; nonparametric data were analysed using the two-sample Wilcoxon test (p < 0.05).
RESULTS: There was no significant difference between groups with regard to age, weight, surgical and anaesthetic duration, incision length, sedation and pain scores. MNT values decreased in both groups at all time points as compared with the baseline. No dog required rescue analgesia. No postoperative complications were observed. CONCLUSION AND CLINICAL RELEVANCE: Bupivacaine IP and carprofen SC after morphine IM did provide satisfactory postoperative analgesia in dogs undergoing OHE with the anaesthetic protocol used. There appears to be no clinical advantage to adding bupivacaine INC. Neither protocol could prevent the development of primary hyperalgesia.
© 2016 Association of Veterinary Anaesthetists and the American College of Veterinary Anesthesia and Analgesia.

Entities:  

Keywords:  canine; hyperalgesia; local anaesthesia; ovariohysterectomy; pain

Mesh:

Substances:

Year:  2016        PMID: 26870925     DOI: 10.1111/vaa.12348

Source DB:  PubMed          Journal:  Vet Anaesth Analg        ISSN: 1467-2987            Impact factor:   1.648


  5 in total

1.  Cardiorespiratory effects of epidurally administered ketamine or lidocaine in dogs undergoing ovariohysterectomy surgery: a comparative study.

Authors:  A E Miranda-Cortés; A G Ruiz-García; A E Olivera-Ayub; G Garza-Malacara; J G Ruiz-Cervantes; J A Toscano-Zapien; I Hernández-Avalos
Journal:  Iran J Vet Res       Date:  2020       Impact factor: 1.376

2.  Efficacy and pharmacokinetics of bupivacaine with epinephrine or dexmedetomidine after intraperitoneal administration in cats undergoing ovariohysterectomy.

Authors:  Javier Benito; Beatriz Monteiro; Francis Beaudry; Paulo Steagall
Journal:  Can J Vet Res       Date:  2018-04       Impact factor: 1.310

3.  The analgesic and sedative effects of GV20 pharmacopuncture with low-dose hydromorphone in healthy dogs undergoing ovariohysterectomy.

Authors:  Elizabeth M Scallan; Stacy L Eckman; Caleb D Coursey; Kristine C Ikels; Bradley T Simon
Journal:  Can Vet J       Date:  2021-10       Impact factor: 1.008

4.  Evaluation of intraperitoneal administration of morphine on post-operative pain management after ovariohysterectomy in dogs.

Authors:  Aida Rezaeipour; Hadi Naddaf; Seyedeh Missagh Jalali; Soroush Sabiza
Journal:  Vet Med Sci       Date:  2021-11-25

5.  Reasons for Exclusion of Apparently Healthy Mature Adult and Senior Dogs From a Clinical Trial.

Authors:  Nicole H Gibbs; Hannah Michalski; Daniel E L Promislow; Matt Kaeberlein; Kate E Creevy
Journal:  Front Vet Sci       Date:  2021-06-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.